Goldman Sachs’s Teladoc Health TDOC Stock Holding History

Goldman Sachs’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-100,000	Closed	-$2.15M	–	5870
2023 Q4	$2.15M	Hold	100,000	–	–	﹤0.01%	3868
2023 Q3	$1.86M	Hold	100,000	–	–	﹤0.01%	3823
2023 Q2	$2.53M	Sell	100,000 -168,500	-63%	-$4.24M	﹤0.01%	3691
2023 Q1	$6.95M	Sell	268,500 -399,700	-60%	-$10.7M	﹤0.01%	2749
2022 Q4	$15.8M	Buy	668,200 +402,300	+151%	+$10.8M	﹤0.01%	2166
2022 Q3	$6.74M	Buy	+265,900	New	+$9.33M	﹤0.01%	2872
2022 Q2	–	Sell	-56,600	Closed	-$4.08M	–	6713
2022 Q1	$4.08M	Sell	56,600 -103,000	-65%	-$7.42M	﹤0.01%	3538
2021 Q4	$14.7M	Buy	159,600 +103,000	+182%	+$12.3M	﹤0.01%	2411
2021 Q3	$7.18M	Buy	56,600 +20,600	+57%	+$3M	﹤0.01%	3033
2021 Q2	$5.99M	Buy	36,000 +25,300	+236%	+$4.1M	﹤0.01%	3178
2021 Q1	$1.95M	Buy	+10,700	New	+$2.48M	﹤0.01%	4012
2020 Q2	–	Sell	-15,200	Closed	-$2.36M	–	5477
2020 Q1	$2.36M	Buy	+15,200	New	+$1.77M	﹤0.01%	3181

Other funds holding TDOC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's TDOC Position: Q1 2026 in Review

Goldman Sachs increased its Teladoc Health (TDOC) stake by 41% in Q1 2026, buying an estimated $4.39M and bringing the position to 2,706,335 shares worth $14.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2740.

Goldman Sachs first reported a position in TDOC in Q3 2015 and has held it in 41 quarters since. The position peaked at $224M in Q1 2021. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

Goldman Sachs held 2,706,335 shares of Teladoc Health worth $14.7M as of Q1 2026.
Goldman Sachs bought 781,802 Teladoc Health shares in Q1 2026, an estimated $4.39M.
Teladoc Health made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2740 holding.
Goldman Sachs first reported a position in Teladoc Health in Q3 2015 and has held it in 41 quarters since.
Goldman Sachs's Teladoc Health position peaked at $224M in Q1 2021.
323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.